MACSF

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is an insurance provider dedicated to health professionals in France, founded in 1935. It serves approximately 950,000 members across various medical and paramedical specialties, offering a range of professional and personal insurance solutions, as well as services related to savings, financing, and pensions. MACSF's products are designed to meet the evolving needs of its members, supporting them throughout their professional journeys and personal projects.

22 past transactions

Pixmania

Seed Round in 2024
Pixmania is an e-commerce platform focused on consumer electronics, offering a diverse selection of products including new and refurbished smartphones, tablets, speakers, cameras, headphones, and accessories. In addition to its extensive product range, Pixmania also provides estimation and device repair services, allowing customers to access a variety of electronic items at competitive prices. The company's commitment to enhancing the shopping experience positions it as a notable player in the online retail market for consumer electronics.

Singulier

Venture Round in 2023
Singulier is a management consulting firm founded in 2017 and headquartered in Paris, France. The company specializes in digital transformation and provides a range of services including due diligence, investment strategy, digital strategy, customer relationship management, and innovation. Singulier integrates business consultancy with digital design thinking, marketing, technology, and data analysis to address complex business challenges faced by CEOs, executives, and investors. The firm serves a diverse array of sectors, including consumer products, financial services, healthcare, information technology, and marketing, among others. Through its expertise, Singulier aims to deliver rapid and effective solutions tailored to the needs of its clients.

RDS

Seed Round in 2023
RDS is a healthcare technology startup focused on remote patient monitoring solutions. Its flagship product, MultiSense®, is a high-precision, multi-parametric monitoring system that enables healthcare professionals to continuously track patients' physiological parameters in both hospital and home settings. This innovative, multi-patented device combines a wearable monitor with a cloud platform, transforming collected data into actionable clinical insights. RDS targets hospitals, particularly surgical departments, seeking to enhance patient care and reduce hospital stays through early discharge and continuous monitoring, ultimately contributing to significant healthcare savings. The MultiSense® solution is CE marked (MDR) and is available in several European countries. RDS operates on a recurring revenue model through a "fee for service" approach, offering training and support to healthcare professionals for effective implementation. The company's commitment to improving patient pathways has been recognized with multiple awards and validation from completed clinical investigations, supported by a skilled international team with extensive expertise in healthcare and medical devices.

DocCity

Series A in 2023
DocCity LifeSciences specializes in creating high-quality healthcare spaces designed for clinicians and healthcare professionals. The company offers fully furnished, modern consultation rooms and reception areas that are spacious, well-lit, and equipped with the latest technology. In addition to providing physical spaces, DocCity also offers a range of associated services, including administrative support such as secretarial, reception, and accounting services. This comprehensive approach aims to enhance the work environment for healthcare providers, promoting both relaxation and collaboration among professionals.

Gleamer

Series B in 2023
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Braintale

Venture Round in 2023
Braintale is a Paris-based company founded in 2018 that specializes in developing and distributing innovative diagnostic and prognostic tools specifically for brain-injured patients. The company's digital medical care platform is designed for hospitals to effectively analyze MRI reports, providing accessible solutions that meet the needs of healthcare professionals and patients alike. Braintale’s products are grounded in over 15 years of clinical development, focusing on predicting patient outcomes, particularly for those in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. By facilitating easier diagnoses, Braintale aims to enhance patient care in critical settings, ultimately improving the prognosis for individuals with severe brain injuries.

i-Run

Private Equity Round in 2022
i-Run, S.A.S. is a privately held online retailer based in Saint Alban, France, specializing in running and fitness clothing. Founded in 2002, the company focuses on providing a wide range of apparel and gear designed for athletes and fitness enthusiasts. With its emphasis on quality and performance, i-Run caters to the needs of individuals looking to enhance their running and fitness experiences through specialized clothing options.

PIXmania.com

Seed Round in 2022
PIXmania is a pan-European online retailer specializing in electrical products, operating in 26 countries. As a member of the Dixons Retail Group, it has enhanced its market presence across Europe and now serves over 7 million customers. The company offers a diverse range of product categories, catering to various consumer needs in the electronics sector.

HoopCare

Seed Round in 2022
HoopCare is a company focused on enhancing preoperative services to improve patient outcomes and reduce surgical risks. It offers a comprehensive range of services, including cardiology evaluations, nutrition counseling, physical therapy, EKG, echocardiography, and stress testing. The company has developed an innovative assessment platform that utilizes a 10-minute patient health questionnaire, analyzed by a machine learning algorithm. This platform automatically scans and evaluates drug prescriptions and blood tests, providing a tailored preparation plan for patients. Furthermore, HoopCare facilitates final check-ups with anesthetists, either in person or via telecommunication, helping to reassure patients about their upcoming procedures. By addressing preoperative health factors, HoopCare aims to minimize complications, reduce transfusion risks, and enhance overall safety for surgical patients.

Synapse Medicine

Series B in 2022
Synapse Medicine is a company based in Bordeaux, France, that specializes in developing an online medical intelligence platform aimed at improving drug prescription management for healthcare professionals. Founded in 2017, the company has created a comprehensive knowledge base that utilizes algorithms to deliver reliable and up-to-date information about medications. This platform allows doctors and pharmacists to analyze treatment options in real time, ensuring the safety and efficacy of drug therapies. By working with leading hospitals and digital health companies across the United States, Europe, and Japan, Synapse Medicine is committed to transforming medication management and enhancing patient care through innovative technology solutions.

Resilience

Series A in 2022
Resilience Care is building a software-based solution for cancer treatment providers and patients. By integrating a mobile application with a Remote Patient Monitoring platform, Resilience enhances care by personalizing, humanizing, and improving the care pathway. The mobile application aids individuals affected by cancer in managing treatment-related side effects and promoting self-care. Simultaneously, the Remote Patient Monitoring platform, classified as a Class IIa medical device, allows healthcare professionals to better understand and improve patient care.

Wandercraft

Series C in 2022
Wandercraft is a pioneering company that develops and sells advanced exoskeletons designed to enable autonomous, self-balanced walking for individuals with mobility impairments. Its flagship product, Atalante, which received CE marking in 2019, is utilized in European rehabilitation hospitals to facilitate gait re-learning treatments. The company is in the process of obtaining FDA approval for its technology. Wandercraft's exoskeletons are distinguished by their realistic gait capabilities, allowing users to walk without crutches or additional aids. In addition to its rehabilitation products, the company is also working on a more agile Personal Mobility exoskeleton intended for everyday use. Wandercraft integrates expertise in algorithmics, artificial intelligence, robotics, production, and clinical practices, positioning itself as a leader in the development of innovative mobility solutions for paraplegics and individuals with myopathic conditions.

Lifen

Series C in 2021
Lifen, a 160-employee Paris-based startup, specializes in streamlining medical data communication. Founded in 2015, it has become France's leading MSSanté operator, serving over 600 healthcare establishments and facilitating monthly exchanges of 2 million medical documents among 240,000 doctors. Lifen's platform simplifies data sharing through secure email, reducing paper mail and automating communication mode identification. Recognized for its interoperability expertise, Lifen aims to develop a platform that eases integration and deployment of digital solutions in healthcare.

Ledger

Series C in 2021
Ledger is a prominent company specializing in security and infrastructure solutions for cryptocurrencies and blockchain applications, established in 2014 and headquartered in Paris, France. The company has become a leader in the market with over one million hardware security devices sold across more than 165 countries. Its flagship products, including the Ledger Nano S and Ledger Nano X, are designed for secure management of cryptocurrencies, featuring built-in displays and connectivity options for ease of use. For enterprises, Ledger offers Ledger Vault, a fully managed SaaS solution that safeguards substantial amounts of multiple cryptocurrencies while addressing physical and IT security threats. Additionally, Ledger is actively engaged in the industrial Internet of Things (IoT) sector, utilizing its secure hardware technology to connect sensors and machines to blockchain-based assets. The company also operates a production facility in Vierzon, France, and maintains offices in San Francisco.

Savana

Series B in 2020
Savana is a medical technology company based in Madrid, Spain, founded in 2014. It has developed an innovative platform that utilizes artificial intelligence to analyze unstructured free-text data within electronic health records (EHRs). By applying deep learning techniques, Savana extracts valuable clinical information, facilitating the generation of customized descriptive and predictive research studies. The company operates the world's largest AI-enabled, multi-language, and multi-center research network, which aims to enhance clinical research and advance personalized and precision medicine globally. Designed by medical professionals for their peers, Savana prioritizes privacy and adheres to high standards of data protection in its operations.

Gleamer

Series A in 2020
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Synapse Medicine

Venture Round in 2020
Synapse Medicine is a company based in Bordeaux, France, that specializes in developing an online medical intelligence platform aimed at improving drug prescription management for healthcare professionals. Founded in 2017, the company has created a comprehensive knowledge base that utilizes algorithms to deliver reliable and up-to-date information about medications. This platform allows doctors and pharmacists to analyze treatment options in real time, ensuring the safety and efficacy of drug therapies. By working with leading hospitals and digital health companies across the United States, Europe, and Japan, Synapse Medicine is committed to transforming medication management and enhancing patient care through innovative technology solutions.

Owkin

Series A in 2020
Owkin, Inc. is an artificial intelligence company that specializes in developing software aimed at improving treatment outcomes for patients, particularly in oncology. Established in 2016, with headquarters in New York and an office in Paris, Owkin employs AI tools to enhance drug discovery and accelerate clinical trials while safeguarding patient privacy through federated learning. The company offers several products, including Owkin Lab for therapeutic data connection, Owkin Loop for validated and packaged models, and a comprehensive software stack. Owkin's portfolio includes 30 live models, with an additional 40 in development, focusing on identifying new drug candidates and elucidating the mechanisms behind treatment efficacy. Co-founded by Thomas Clozel, a clinical research doctor, and Gilles Wainrib, a machine learning expert, Owkin has raised over $255 million and achieved unicorn status due to its innovative approach in addressing unmet medical needs and optimizing the drug development process.

Wellium

Venture Round in 2020
Wellium SAS is a company focused on digital transformation in the medical sector, founded in 2016 and located in Levallois-Perret, France. It specializes in teleconsultation solutions, providing tools that facilitate online consultations between doctors and patients. One of its key offerings is Feelae, an application designed to address issues such as medical desertification and overcrowding in emergency services by enabling patients to receive care remotely. Additionally, Wellium provides Leah, a teleconsultation solution tailored specifically for medical professionals. Through these services, Wellium aims to enhance accessibility and efficiency in healthcare delivery.

BitFury

Venture Round in 2018
BitFury is a leading provider of full-service blockchain technology, specializing in both software and hardware solutions. It secures and facilitates the movement of assets across blockchain networks, offering advanced security and infrastructure through private blockchain networks. The company's offerings include custom semiconductor chips and mobile data centers, catering to businesses, governments, and organizations worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.